Les premiers cas d'infection dus à un nouveau Coronavirus, le SARS-CoV-2 ont été enregistrés en Chine en décembre 2019. Cette maladie, désormais appelée COVID-19, a été déclarée comme pandémie par l'Organisation Mondiale de la Santé (OMS) trois mois après soit en mars 2020. Le plus souvent à l´origine d´un syndrome infectieux sans gravité, associant à différents degrés des symptômes bénins (fièvre, toux, myalgies, céphalées et éventuels troubles digestifs). Le SARS-CoV-2 peut être à l´origine de pathologies pulmonaires graves et parfois de décès. Les données sur les conséquences pendant la grossesse sont limitées. À l'heure actuelle, les données concernant l'infection par SARS-CoV-2 sont rassurantes et n'indiquent pas un nombre d'infection plus élevé ni un risque surajouté de complications chez la femme enceinte par rapport à la population générale. Quelques exceptionnels cas de mortalité maternelle existent, mais surviennent le plus souvent sur des terrains qui présentent d'autres pathologies, particulièrement la pré-éclampsie. L´objectif de notre travail est de rapporter les données cliniques, biologiques et évolutives materno-fœtales, à travers une étude rétrospective au sein de l´Hôpital Militaire Marocain COVID-19 de Benslimane, s´étalant sur une période de 3 mois allant du 21 juillet au 21 octobre 2020.
Minimally invasive gynecologic surgery such as hysteroscopy has a low risk of complications. Infections, however, are more common in the presence of risk factors such as smoking, history of pelvic inflammatory disease, and endometriosis. We report the case of a patient who underwent operative hysteroscopy without immediate complications and was admitted 2 days later to the emergency department in a severe state of septic shock. With multiple organ failures requiring admission to an intensive care unit, the patient died despite extensive antibiotic therapy and vasoactive drugs. Ascending infection can be a potentially fatal complication of hysteroscopy, even in the absence of known risk factors.
This article discusses the rare clinical situation where cervical cancer mimics the symptoms of a cervical myoma. Cervical cancer is a prevalent cancer in women, often caused by HPV infection, and can cause symptoms such as abnormal vaginal bleeding and pain during sexual intercourse. However, cervical myoma can also cause similar symptoms, making it difficult to differentiate between the two conditions. Delayed diagnosis and treatment of cervical cancer can lead to a poorer outcome for patients, highlighting the importance of accurately identifying the disease. Healthcare professionals should be aware of this rare clinical situation and conduct thorough examinations to differentiate between cervical cancer and cervical myoma. Early diagnosis and appropriate treatment can improve the prognosis for patients with this disease. Women should also be aware of the potential symptoms of cervical cancer and consult a healthcare professional if they experience abnormal vaginal bleeding or pain during sexual intercourse. Vaccination against HPV can help prevent cervical cancer, making it important for women to discuss this option with their healthcare provider. This article reports a case of cervical cancer mimicking a cervical myoma, highlighting the importance of considering this rare clinical situation in differential diagnoses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.